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Most steroidal ointments contain propylene glycol (PG) and surfactants, which improve the solubility of
corticosteroids in white petrolatum. Surfactants aid the uniform dispersal of PG within white petrolatum.
Since the surfactants used in generic ointments are usually different from those used in brand name
ointments, we investigated the effects of surfactants on the rheological properties of three brand name
ointments and six equivalent generic ointments. We detected marked differences in hardness, adhe-
siveness, and spreadability among the ointments. Further examinations of model ointments consisting of
white petrolatum, PG, and surfactants revealed that the abovementioned properties, especially hardness
and adhesiveness, were markedly affected by the surfactants. Since steroidal ointments are often
admixed with moisturizing creams prior to use, we investigated the mixing compatibility of the oint-
ments with heparinoid cream and how this was affected by their surfactants. We found that the oint-
ments containing glyceryl monostearate demonstrated good mixing compatibility, whereas those con-
taining non-ionic surfactants with polyoxyethylene chains exhibited phase separation. These results
were also consistent with the ﬁndings for the model ointments, which indicates that the mixing com-
patibility of steroidal ointments with heparinoid cream is determined by the emulsifying capacity of the
surfactants in their oily bases.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In Japan, the government has suggested that the use of the
generic drugs could help to reduce the cost of the country's
healthcare system, and this also applies to topical medicines such
as ointments. As is the case for orally administered drugs, generic
ointments usually have different ingredients from brand name
ointments [1–4]. For orally administered drugs, differences in
ingredients between brand name and generic drugs usually do not
result in variations in their bioavailability; i.e., clinical tests indi-
cate that they are bioequivalent [5]. On the other hand, for topical
medicines it is likely that differences in the ingredients of brand
name and generic medicines will result in differences in their
rheological properties such as their hardness, adhesiveness,
spreadability, and viscosity, which could in turn affect the way
they feel and/or the skin absorption of the drugs contained withinB.V. This is an open access article u
ethylene; HLB, hydrophilic–
gawa).them. In fact, in a study by Yamamoto et al. of ﬁve brand name
steroidal ointments and seven corresponding generic products,
differences in spreadability were detected between the brand
name ointments and the equivalent generic ointments [2]. They
suggested that the differences in the spreadability of the brand
name and generic products might have been caused by species
and quality differences in the ointment bases and additives used.
Another study found differences in the viscosity and elasticity of
brand name acyclovir creams and two generic products, which
caused them to feel different [6]. Furthermore, differences in the
concentration of solubilized steroids in white petrolatum were
detected by Ohtani et al. [1], which seemed to induce changes in
their physiological activities.
Steroidal ointments often contain propylene glycol (PG) as a
solvent because corticosteroids are poorly soluble in white pet-
rolatum, which is used as a base, and the solubilized concentration
of steroids is often lower than the displayed concentration [1,3]. In
addition to PG, non-ionic surfactants are added to such ointments
to uniformly disperse PG within the white petrolatum base and
increase the solubility of the steroids, although the amounts of PG
and surfactants added seem to be small compared with those usednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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intermediate between those of ointments and oily creams.
Usually, the surfactants contained in generic ointments differ
from those found in brand name ointments. Some ointments
contain surfactants with low hydrophilic–lipophilic balance (HLB)
values, such as glycerol fatty acid esters (usually glyceryl mono-
stearate; HLB 3.8), which are suitable for preparing water-in-oil
emulsions. Other ointments contain surfactants with high HLB
values, such as polyoxyethylene (POE) hydrogenated castor oil 40
(HLB 12.5) and 60 (HLB 14.0), and POE(10) oleyl ether (HLB 12.4).
These surfactants are suitable for preparing oil-in-water emulsions
[7]. However, few studies have examined the differences between
the rheological properties of brand name ointments and the
equivalent generic ointments as mentioned above [2,4,6]. Fur-
thermore, no previous studies clariﬁed the effects of particular
surfactants on the rheological properties of steroidal ointments.
Steroidal ointments are often prescribed together with moist-
urizing creams during the treatment of atopic dermatology and
psoriasis, and admixtures of steroidal ointments and moisturizing
creams are often prepared to improve patient compliance [8–11].
However, it is possible that the production of such admixtures
changes the release proﬁles of the steroids within them [12,13].
In vitro studies have also suggested that the production of such
admixtures also inﬂuences the permeability and skin penetration
of the steroids within them [8,14]. Furthermore, admixing ster-
oidal ointments with other semisolid formulations often causes
the steroids to degrade [15].
In addition, problems associated with mixing incompatibility,
such as phase separation and bleeding, have also been detected in
admixtures of two different ointments, an ointment and a cream,
or two different creams [9,12,15,16]. Although it is possible that
the mixing compatibility of brand name steroidal ointments and
the equivalent generic ointments differs due to differences in their
surfactants, no previous studies have clariﬁed the effects of par-
ticular ointment surfactants on the mixing compatibility of ster-
oidal ointments with other ointments and creams.
Therefore, in this study we ﬁrst compared the rheological
properties (the hardness, adhesiveness, and spreadability) of three
brand name ointments and six equivalent generic ointments
containing diﬂuprednate, dexamethasone propionate, or clobeta-
sol propionate. In addition, we examined the effects of particular
surfactants on the abovementioned properties by preparing model
ointments consisting of white petrolatum, PG, and a surfactant,
which are present in each of the examined brand name/generic
ointments, and assessed their rheological properties. We also
investigated the mixing compatibility of the steroidal ointments
with a brand name oil-in-water type heparinoid cream and the
inﬂuence of their surfactants on this because steroidal ointments
are often admixed with oil-in-water type or water-in-oil type
heparinoid cream in the clinical setting. Throughout this study, we
tried to clarify the relationships between the hydrophilic/hydro-
phobic nature of the surfactants contained within the ointments
and the ointments' rheological properties or mixing compatibility.2. Materials and methods
2.1. Materials
The following steroidal ointments were used: Mysers oint-
ment (Mitsubishi Tanabe Pharma Co., Osaka, Japan), which con-
tains 0.05% diﬂuprednate, and two equivalent generic products,
Saibaths ointment (Maeda Pharmaceutical Industry Co., Toyama,
Japan) and Stibrons ointment (Iwaki Seiyaku Co., Tokyo, Japan);
Methaderms ointment (Okayama Taiho Pharmaceutical Co., Bizen,
Japan), which contains 0.1% dexamethasone propionate, and twoequivalent generic products, Mainvates ointment (Maeda Phar-
maceutical Industry Co.) and Delmusatts ointment (Toko Phar-
maceutical Industrial Co., Tokyo, Japan); and Dermovates oint-
ment (GlaxoSmithKline K.K., Tokyo, Japan), which contains 0.05%
clobetasol propionate, and two equivalent generic products, Der-
topicas ointment (Iwaki Seiyaku Co.) and Myalones ointment
(Maeda Pharmaceutical Industry Co.). Hirudoids cream (Maruho
Co., Osaka, Japan) was used as a heparinoid cream, and Sunwhites
P-1 (Nikko Rika Co., Tokyo, Japan) was used as a high-grade white
petrolatum product. High-grade POE hydrogenated castor oil 40
and 60 were kindly provided by Nikko Chemicals (Tokyo, Japan),
and POE(40) sorbitan tetraoleate was also kindly donated by NOF
Co. (Tokyo, Japan). Glyceryl monostearate, sorbitan sesquioleate,
POE(7) oleyl ether, POE(50) oleyl ether and all other reagents were
obtained from Wako Pure Chemical Industries (Osaka, Japan).
2.2. Evaluation of the ointments' hardness and adhesiveness
The hardness and adhesiveness of the ointments containing
diﬂuprednate, dexamethasone propionate, or clobetasol propio-
nate, as well as those of the model ointments were measured with
a COMPAC-100II rheometer (Sun Scientiﬁc Co., Tokyo, Japan) at
room temperature (about 25 °C) by recording the loads at which
the loading bar (diameter:10 mm) was inserted to a depth of 5 mm
and detached at a table travel speed of 60 mm/min, respectively.
The hardness of each ointment was obtained from the level at
which the insertion load plateaued. The adhesiveness of each
ointment was assessed based on the area under the curve of the
load following the detachment of the loading bar.
2.3. Evaluation of the ointments' spreadability
The spreadability of the ointments was evaluated with a spread
meter (Imoto Machinery Co., Kyoto, Japan). The ointments were
spread on the plate of the spread meter at room temperature
(about 25 °C), and then the changes in their diameters were
measured at 20, 30, 50, 100, 200, and 500 s after the addition of a
load [17]. The spreadability of the ointments was assessed from
the slope of the regression line between the logarithm of the time
since the addition of the load and the diameter of the ointment
after it was spread on the plate.
2.4. Microscopic analysis
The internal structures of the ointments were examined by
microscopic analysis using a BX53 microscope (Olympus, Tokyo,
Japan) equipped with a phase contrast observation system at
magniﬁcation of 1000 times.
2.5. Preparation of model ointments
Model ointments were prepared by melting white petrolatum
at 75 °C in the presence of PG and surfactants under gentle mixing.
The model ointments were obtained by allowing the mixtures to
cool down to room temperature. The concentration of PG was kept
at 10% w/w.
2.6. Examination of mixing compatibility
The mixing compatibility of the steroidal ointments with a
brand name heparinoid cream was examined using a quick
centrifugation-based test of phase separation: an optical exam-
ination assessing the extent of phase separation after the mixture
had been subjected to centrifugation. Five grams of each steroidal
ointment were added to an equal amount of the brand name
heparinoid cream, Hirudoids cream, and mixed twice with an NR-
S. Kitagawa et al. / Results in Pharma Sciences 6 (2016) 7–14 950 rotation/revolution mixer (Thinky Co., Tokyo, Japan) at
1000 rpm for 30 s. The admixture was then inserted into a glass
centrifuge tube and centrifuged at 3000 rpm for 10 min with a KN-
70 centrifuge (Kubota Co., Tokyo, Japan). Then, the change in the
appearance of the mixture, e.g., whether any phase separation or
bleeding occurred, was examined. Mixing compatibility was also
examined by microscopically examining the structure of each
ointment and cream admixture using samples that had not yet
been subjected to centrifugation.
The mixing compatibility with Hirudoids cream of model
ointments containing various amounts of surfactants was exam-
ined using the centrifugation method. The ratio of the separated
phase to the whole length of the admixture was used as an index
of mixing compatibility.3. Results
3.1. Hardness and adhesiveness of brand name and generic oint-
ments containing diﬂuprednate, dexamethasone propionate, or clo-
betasol propionate
We examined the rheological properties of brand name and
generic ointments containing diﬂuprednate, dexamethasone pro-
pionate, or clobetasol propionate, whose constituents are shown
in Table 1. As rheological properties, we ﬁrst measured hardness
and adhesiveness, which have an important impact on how an
ointment feels [18,19]. Since the ointments' rheological properties
might have changed over time due to the oxidation of the white
petrolatum within them, we carried out the experiments within
two months of the ointment bottles being opened.Table 1
Additives other than white petrolatum and propylene glycol that were contained in
brand name and generic ointments containing 0.05% diﬂuprednate (a), 0.1% dex-
amethasone propionate (b), or 0.05% clobetasol propionate (c).
(a)
A (brand-name) B (generic) C (generic)
Mysers ointment Saibaths ointment Stibrons ointment
POE oleyl ether POE hydrogenated castor oil 60 Glyceryl monostearate
White beeswax Liquid parafﬁn
Liquid parafﬁn White beeswax
pH adjuster
(b)
D (brand-name) E (generic) F (generic)
Methaderms ointment Mainvates ointment Delmusatts ointment
Glyceryl monostearate POE hydrogenated
castor oil 40
POE sorbitan tetraoleate




G (brand-name) H (generic) I (generic)
Dermovates ointment Dertopicas ointment Myalones ointment
Sorbitan sesquioleate Glyceryl monostearate POE hydrogenated
castor oil 40
White beeswax Citric acid hydrate
Liquid parafﬁn
Adipic acid isopropionate
pH adjusterThe hardness and adhesiveness of the ointments differed, as
shown in Fig. 1a for ointments A, B, and C, which all contained
diﬂuprednate. The hardness and adhesiveness of generic ointment
C were about 2.5-fold greater than those of brand name ointment
A and generic ointment B. Likewise, as shown for the brand name
and generic ointments containing dexamethasone propionate
(ointments D, E, and F; Fig. 1b) or clobetasol propionate (ointments
G, H, and I; Fig. 1c), the hardness and adhesiveness of the oint-
ments differed. The hardness and adhesiveness of the total nine
ointments exhibited the following order: G, C4H4D4E, F,
I4B4A. Among the ﬁrst four ointments, ointments C, H, and D
contained glyceryl monostearate, and ointment G contained sor-
bitan sesquioleate, as a surfactant, respectively. These surfactants
have low HLB values and are used for preparing water-in-oil
emulsions. On the other hand, ointments E, F, I, B, and A, which
exhibited low hardness and adhesiveness values, contained sur-
factants with POE chains; i.e., POE oleyl ether (ointment A), POE
hydrogenated castor oil 60 (ointment B), POE hydrogenated castor
oil 40 (ointments E and I) or POE sorbitan tetraoleate (ointment F).
These surfactants have high HLB values, which are considered to
be useful for preparing oil-in-water emulsions. These ﬁndings
suggest that the physicochemical properties of the ointments'
surfactants modiﬁed the hardness and adhesiveness of the
ointments.
3.2. Spreadability of brand name and generic ointments containing
diﬂuprednate, dexamethasone propionate, or clobetasol propionate
We next examined the spreadability of the ointments.
Spreadability is also an important physicochemical property of
ointments because it is an indicator of the utility of the ointment
[6,19]. As shown in Fig. 2a–c, spreadability also differed among the
ointments. The spreadability of the ointments exhibited the fol-
lowing order: F4E4B4 I4D4GcA4H4C. Ointments A, C,
and H were markedly less spreadable than the other ointments.
Interestingly, ointments A, C, and H contained white beeswax as
an additive, whereas the other ointments did not. Therefore, the
presence of white beeswax might result in a reduction in
spreadability. The surfactant glyceryl monostearate also seems to
be associated with reduced spreadability because the spreadability
of ointments C, D, and H, which contained glyceryl monostearate,
was low (C and H) or moderate (D). On the other hand, the oint-
ments that contained surfactants with POE chains in the absence
of white beeswax exhibited excellent spreadability (B, E, F, and I).
Therefore, surfactants also seem to affect ointment spreadability.
3.3. Hardness and adhesiveness of model ointments containing
propylene glycol and surfactants
The present ﬁndings indicated that surfactants have marked effects
on the rheological properties of ointments, especially their hardness
and adhesiveness. To elucidate the contributions of each ingredient to
the ointments' hardness and adhesiveness, we prepared model oint-
ments consisting of white petrolatum and 10% w/w PG and 5% w/w
surfactants. As shown in Fig. 3a, the addition of PG decreased the
hardness and adhesiveness of the model ointments by about 50%. The
subsequent addition of 5% w/w glyceryl monostearate restored the
hardness and adhesiveness of the model ointments to almost baseline
levels. On the other hand, the addition of the same concentration of a
POE chain-containing surfactant (POE hydrogenated castor oil 40 or
POE(40) sorbitan tetraoleate) resulted in slightly decreased hardness
and adhesiveness values.
We also examined the concentration-dependent effects of glyceryl
monostearate and a POE chain-containing surfactant (POE(50) oleyl
ether) (concentration of glyceryl monostearate:1–5% w/w; con-





























































Fig. 1. The hardness and adhesiveness of brand name and generic ointments containing diﬂuprednate (a), dexamethasone propionate (b), or clobetasol propionate (c) A, D,
and G: brand name ointments; B, C, E, F, H, and I: generic ointments The hardness of the ointment was assessed from the level at which the insertion load plateaued, whereas






















































Fig. 2. Spreadability of brand name and generic ointments containing diﬂuprednate (a), dexamethasone propionate (b) or clobetasol propionate (c). A, D, and G: brand name
ointments; B, C, E, F, H, and I: generic ointments. Data are shown as the means7S.D. of four experiments. The slopes of the plotted lines (A, 0.96; B, 4.98; C, 0.72; D, 4.09; E,
5.17; F, 6.42; G, 3.93; H, 0.83; I, 4.30) represent the spreadability of the ointments.
S. Kitagawa et al. / Results in Pharma Sciences 6 (2016) 7–1410addition of glyceryl monostearate resulted in dose-dependent increa-
ses in hardness and adhesiveness (up to approximately twice their
original values at a concentration of 5% w/w). On the other hand, POE
(50) oleyl ether caused slight reductions in hardness and adhesiveness
at 5% w/w. Interestingly, it induced dose-dependent increases in these
parameters at higher concentrations, but even at 20% w/w, the
increases were less marked than those induced by 5% w/w glyceryl
monostearate, as shown in Fig. 3c. These results were consistent with
the ﬁndings obtained for the commercially available ointments
(Fig. 1a–c).
3.4. Structures of brand name and generic ointments
To clarify how the surfactants affected the rheological properties of
the ointments, we examined the ointments' structures micro-
scopically. As shown in Fig. 4a–c for the ointments containing diﬂu-
prednate, particle dispersion (presumably PG particles) was observedin all of the ointments. In particular, a homogeneous particle structure
was observed in the ointments containing glyceryl monostearate,
which is considered to be a useful surfactant for preparing water-in-oil
emulsions, as shown in Fig. 4c for ointment C.
3.5. Mixing compatibility of brand name and generic ointments with
heparinoid cream
Steroidal ointments are used to treat patients suffering from atopic
dermatitis. In this setting, they are often mixed with a moisturizing
cream such as heparinoid cream to improve patient compliance.
However, mixing ointments with creams often induces phase
separation or bleeding [12,16,20]. Therefore, the mixing compatibility
of the steroidal ointments with a brand name oil-in-water emulsion-
type heparinoid cream (such admixtures are often used clinically) was
examined using a quick centrifugation-based test of phase separation



































































Fig. 3. Effects of surfactants on the hardness and adhesiveness of model ointments consisting of white petrolatum, propylene glycol, and surfactants. Data are shown as
means of four experiments. In the presence of PG, its concentration was kept at 10% w/w. In the experiment shown in Fig. 3a, the concentration of the surfactants was kept at
5% w/w; (i) without additives, (ii) with PG, (iii) with PG and glyceryl monostearate, (iv) with PG and POE hydrogenated castor oil 40, (v) with PG and POE(40) sorbitan
tetraoleate. In the experiments shown in Fig. 3b for the effects of glyceryl monostearate and in Fig. 3c for POE(50) oleyl ether, respectively, the numbers represent the
concentrations of the surfactants expressed as percentage weight values.
Fig. 4. Phase contrast micrograph of brand name and generic ointments containing diﬂuprednate. (a) Brand name ointment A, (b) generic ointment B, and (c) generic
ointment C.
S. Kitagawa et al. / Results in Pharma Sciences 6 (2016) 7–14 11contains glycerol and isopropyl alcohol as hydrophilic solvents and
white petrolatum as a hydrophobic base. As for its main surfactant, it
contains stearic acid and potassium hydroxide, which react to produce
potassium stearate.
Photographs obtained during the centrifugation-based examina-
tions of the ointments containing diﬂuprednate (ointments A, B, and
C) are shown in Fig. 5 as examples. Homogeneous mixing was
observed in the admixtures composed of ointment C, D, G, or H and
heparinoid cream (weight ratio:1:1). These ointments contained gly-
ceryl monostearate (ointments C, D, and H) or sorbitan sesquioleate
(ointment G). These surfactants have low HLB values and are suitable
for preparing water-in-oil emulsions. On the other hand, phase
separation was seen in the admixtures containing ointment A, B, E, F,
or I and heparinoid cream at a weight ratio of 1:1. All of these oint-
ments contain surfactants with POE chains; i.e., POE oleyl ether
(ointment A), POE hydrogenated castor oil 60 (ointment B) or 40
(ointments E and I), or POE sorbitan tetraoleate (ointment F). These
surfactants become hydrophilic via the formation of hydrogen bonds
between the ether oxygen atoms of their oxyethylene chains andwater molecules; therefore, they have high HLB values and are suitable
for preparing oil-in-water emulsions. These ﬁndings suggest that the
physicochemical properties of the surfactants in the steroidal oint-
ments determined their mixing compatibility with heparinoid cream.3.6. Effects of surfactants on the mixing compatibility of white pet-
rolatum with heparinoid cream in the presence of propylene glycol
To examine the abovementioned suggestion, we investigated the
effects of the surfactants on the mixing compatibility of white petro-
latum with heparinoid cream in the presence of 10% w/w PG. As
shown in Fig. 6, which shows the dose-dependent effects of the sur-
factants, glyceryl monostearate induced homogeneous mixing at the
lowest concentration, and sorbitan sesquioleate induced it at the next
lowest concentration. Grifﬁn reported HLB values of 3.8 for glyceryl
monostearate and 3.7 for sorbitan sesquioleate [21], but in calculations
based on their theoretical chemical formulas Pasquali et al. suggested
that these surfactants have HLB values of 4.1 and 4.9, respectively [22].
Fig. 5. Mixing compatibility of admixtures with heparinoid cream of brand name or generic ointments containing diﬂuprednate at one to one weight ratio. (a) Brand name








0.01 0.1 1 10 100












Fig. 6. Effects of surfactants on the phase separation of admixtures with heparinoid
cream of model ointments at one to one weight ratio. The length of the separated
upper layer in the absence of surfactants was deﬁned as 1.0. The closed diamonds,
open circles, open squares, open triangles, closed squares, and closed triangles,
indicate the results for the ointments containing glyceryl monostearate, sorbitan
sesquioleate, POE(40) hydrogenated castor oil, POE(7) oleyl ether, POE(50) oleyl
ether, POE(40) sorbitan tetraoleate, respectively. Data are shown as the means7S.
D. of four experiments.
S. Kitagawa et al. / Results in Pharma Sciences 6 (2016) 7–1412The calculations performed by Pasquali et al. produced more accurate
results for surfactants without POE chains.
Higher concentrations of the POE hydrogenated castor oil 40
(HLB:12.5), POE(7) oleyl ether (HLB:10.7), POE(50) oleyl ether
(HLB:18.0), and POE(40) sorbitan tetraoleate (HLB:11.8) were required
to induce homogeneous mixing. POE(7) oleyl ether, which is more
hydrophobic than POE(50) oleyl ether, was fully effective at lower
concentrations than POE(50) oleyl ether. These ﬁndings agree with our
speculation based on the results shown in Fig. 5, and suggest that the
mixing compatibility of steroidal ointments with heparinoid cream isdetermined by the HLB values of their surfactants; i.e. the emulsifying
capacity of their surfactants in oily conditions.4. Discussion
To allay patients' concerns regarding the use of generic medi-
cines, it should be conﬁrmed that particular brand name and
generic drugs are bioequivalent, and such drug pairs should also
produce similar sensations during their use. However, as was
revealed in the present study of steroidal ointments, the rheolo-
gical properties of ointments can vary markedly due to differences
in their ingredients, as suggested by previous studies [2,6]. The
ﬁndings obtained for the ointments containing diﬂuprednate,
dexamethasone propionate, or clobetasol propionate, and those
acquired for the model ointments indicated that certain rheolo-
gical properties, especially low hardness and adhesiveness values,
are associated with the use of surfactants containing POE chains to
promote the dispersal of PG, which is often added to steroidal
ointments to improve the solubility of the steroids in the ointment
base. As for hardness and adhesiveness, the dispersion state of the
hydrophilic solvent seems to be important. The relatively large
liquid particles found in the ointments containing surfactants with
POE chains seemed to reduce the ointments' hardness and
adhesiveness.
The spreadability values of the steroidal ointments exhibited a
different order (from highest to lowest) from their hardness and
adhesiveness values. Therefore, it is reasonable to assume that
different factors affect each rheological property. The network
structure of the solid components of petrolatum within its liquid
components is expected to play an essential role in spreadability,
since this is a typical feature of semi-solid materials. The present
ﬁndings suggested that white beeswax might change the balance
S. Kitagawa et al. / Results in Pharma Sciences 6 (2016) 7–14 13of the solid materials and liquid materials, and result in a reduc-
tion in spreadability. Further studies are necessary to reveal the
mechanisms responsible for the effects of each component on
ointment spreadability.
Variations in the properties of white petrolatum, which is used
as an ointment base, can also affect ointments' rheological prop-
erties because the rheological properties, especially the viscosity,
of white petrolatum might vary among different manufacturers
(under investigation). Moreover, the apparatus and manufacturing
processes used by each steroidal ointment manufacturer are
known to differ, which might also affect the rheological properties
of steroidal ointments. It has been reported that the rheological
properties of ointments are affected by the network structure of
the solid components of petrolatum within its liquid components
[23]. However, it remains unclear how the network structure of
white petrolatum affects each rheological property.
Topical formulations are often admixed with white petrolatum,
other ointments, or creams. Such mixing induces changes in their
rheological properties, stability, and the skin permeation of their
active ingredients [8,11–14,20,24–26]. It is possible that differ-
ences in the rheological properties of steroidal ointments affect
the skin permeation of their active ingredients since it has been
reported that the rheological properties of creams inﬂuence the
skin permeation of their active ingredients [24,25]. Further studies
are required to examine this issue.
Moreover, such mixing can cause phase separation or bleeding
[12,16,20]. The present studies on the mixing compatibility of
steroidal ointments with oil-in-water emulsion-type heparinoid
cream have revealed that ointments that contain glyceryl mono-
stearate as a surfactant display good mixing compatibility, and
ointments containing non-ionic surfactants with POE chains
demonstrate mixing incompatibility, although stability tests are
required to conﬁrm these ﬁndings. As for the mixing compatibility
of ointments containing sorbitan sesquioleate with heparinoid
cream, it seems to vary according to the results revealed in this
study and those of another study on other steroidal ointments
containing this surfactant (under investigation).
In the present study, experiments involving model ointments
indicated that the mixing compatibility of steroidal ointments
with heparinoid cream can be predicted based on HLB values
calculated from their theoretical chemical formula (it has been
reported that such values are able to predict the hydrophilicity/
hydrophobicity of surfactants without POE chains more accu-
rately) [22]. Heparinoid cream contains potassium stearate as its
main surfactant, which is produced via a reaction between the
cream's constituents; i.e., stearic acid and potassium hydroxide. It
also contains alkyl alcohols as co-surfactant components. How-
ever, heparinoid cream does not seem to form stable emulsions
when it is mixed with steroidal ointments in which oily white
petrolatum is employed as a base.
The obtained ﬁndings suggest that the mixing compatibility of
ointments containing oily bases with heparinoid cream is deter-
mined by the emulsifying capacity of the ointments' surfactants in
oil-rich conditions. Therefore, we can estimate the compatibility of
steroidal ointments with heparinoid cream by checking what
surfactants they contain. We are currently attempting to establish
rules for determining the mixing compatibility of ointments with
other ointments and creams including water-in-oil emulsion type
creams based on the surfactants contained within the ointments.5. Conclusion
We detected marked differences in the hardness, adhesiveness
and spreadability of three brand name and six generic ointments
containing diﬂuprednate, dexamethasone propionate, orclobetasol propionate. The present ﬁndings regarding commer-
cially available ointments and model ointments indicate that the
rheological properties of steroidal ointments, especially their
hardness and adhesiveness, are determined by the presence of PG
and the surfactants they contain, which seems to be related to the
dispersion state of PG in the oily base.
Experiments examining the mixing compatibility of various
steroidal ointments with heparinoid cream revealed that oint-
ments containing glyceryl monostearate as a surfactant exhibited
good mixing compatibility. On the other hand, ointments con-
taining non-ionic surfactants with POE chains displayed mixing
incompatibility. These ﬁndings were consistent with those
obtained in the experiments involving model ointments. The
results of this study indicate that the mixing compatibility of
ointments that contain white petrolatum as a base with hepar-
inoid cream is determined by the emulsifying capacity of the
ointments' surfactants. Therefore, during the selection of steroidal
ointments, attention should be paid to the surfactants they
contain.Conﬂicts of interest
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